This analysis has been updated to clarify that a pending federal court case has the potential to revoke the approval of mifepristone’s use for medication abortion, but it would not ban all forms of medication abortion. While 98% of medication abortions in the United States in 2020 used a regimen of mifepristone and misoprostol in combination, misoprostol can be used on its own to end a pregnancy. If mifepristone becomes unavailable, it is unclear whether all current providers using the two-drug regimen would offer abortion care using only misoprostol and to what extent patients would take up this method. The fact remains that revoking approval of mifepristone would go against an overwhelming body of scientific evidence that the drug is safe and effective. Banning mifepristone would cause massive disruptions to abortion provision in the United States and patients’ ability to get the timely care they need and deserve.
No comments:
Post a Comment